- Home
- STRT vs TLSI Comparison
STRT vs TLSI Comparison
Compare STRT & TLSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- STRT
- TLSI
- Stock Information
- Founded
- STRT 1908
- TLSI 2010
- Country
- STRT United States
- TLSI United States
- Employees
- STRT N/A
- TLSI N/A
- Industry
- STRT Auto Parts:O.E.M.
- TLSI Medical Specialities
- Sector
- STRT Consumer Discretionary
- TLSI Health Care
- Exchange
- STRT Nasdaq
- TLSI Nasdaq
- Market Cap
- STRT 180.9M
- TLSI 160.4M
- IPO Year
- STRT 1995
- TLSI N/A
- Fundamental
- Price
- STRT $39.78
- TLSI $5.62
- Analyst Decision
- STRT
- TLSI Strong Buy
- Analyst Count
- STRT 0
- TLSI 6
- Target Price
- STRT N/A
- TLSI $11.75
- AVG Volume (30 Days)
- STRT 21.7K
- TLSI 66.8K
- Earning Date
- STRT 05-08-2025
- TLSI 03-27-2025
- Dividend Yield
- STRT N/A
- TLSI N/A
- EPS Growth
- STRT 6726.37
- TLSI N/A
- EPS
- STRT 4.00
- TLSI N/A
- Revenue
- STRT $552,799,000.00
- TLSI $29,431,000.00
- Revenue This Year
- STRT $4.66
- TLSI $55.43
- Revenue Next Year
- STRT $3.38
- TLSI $50.09
- P/E Ratio
- STRT $9.95
- TLSI N/A
- Revenue Growth
- STRT 7.69
- TLSI 58.99
- 52 Week Low
- STRT $21.05
- TLSI $3.50
- 52 Week High
- STRT $53.01
- TLSI $10.42
- Technical
- Relative Strength Index (RSI)
- STRT 35.82
- TLSI 55.78
- Support Level
- STRT $41.91
- TLSI $5.06
- Resistance Level
- STRT $43.52
- TLSI $5.72
- Average True Range (ATR)
- STRT 1.63
- TLSI 0.37
- MACD
- STRT -0.54
- TLSI 0.03
- Stochastic Oscillator
- STRT 7.18
- TLSI 90.65
About STRT STRATTEC SECURITY CORPORATION
Strattec Security Corp designs develops, manufactures, and markets mechanical locks, electronically enhanced locks, and keys. It also produces ignition lock housings; and access control products, including latches, power sliding door systems, and door handles. Strattec ships products to customer locations in the United States, Canada, Mexico, Europe, South America, Korea, and China, and provides full-service aftermarket support. Strattec also supplies products for the heavy truck and recreational vehicle markets, as well as precision, die castings.
About TLSI TriSalus Life Sciences Inc.
TriSalus Life Sciences Inc is engaged in the research, development, and sales of innovative drug delivery technology and immune-oncology therapeutics to improve outcomes in difficult-to-treat liver and pancreatic cancer. It is developing and marketing two product lines Pressure Enabled Drug Delivery (PEDD) infusion systems, in use today, and an investigational agent, nelitolimod (SD-101), which shows potential to enhance immune system response in the treatment of hepatocellular cancer, pancreatic cancer and other liver solid tumors. TriNav is the newest therapy delivery device with SmartValve technology for the proprietary PEDD approach.